MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report.
Karakaş
Z
Z
Istanbul University School of Medicine, Department of Hematology/Oncology, Turkey.
Ağaoğlu
L
L
Erdem
S
S
Anak
S
S
Hacibektaşoğlu
A
A
Gedikoğlu
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity*; D001853:Bone Marrow / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use* / Q000633:toxicity; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use* / Q000633:toxicity; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D011237:Predictive Value of Tests; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D016572:Cyclosporine; D015255:Idarubicin